Novel Elongator Protein 2 Inhibitors Mitigating Tumor Necrosis Factor-α Induced Osteogenic Differentiation Inhibition

Figure 7

The expression of osteogenic differentiation markers were increased by the 2# and 5# drug candidates compared with TNF-α treatment in the cell differentiation process. The protein of the differentiation model cells was harvested on the 7th day after osteoblast cell differentiation and then subjected to Western blot analysis.

(a)

(b)